pentobarbital will lower the extent or result of ketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Not known.
Use or redistribution of any DrugBank content or info demands a license and good citations. Talk with income for business licensing. Submit an application for an academic license.
pentobarbital will lessen the extent or outcome of nelfinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
pentobarbital will lower the level or outcome of bosentan by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unknown.
Contraindicated (1)pentobarbital will lessen the level or outcome of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is a delicate CYP3A4 substrate. Coadministration with sturdy or moderate CYP3A4 inducers is contraindicated.
pentobarbital will lower the extent or outcome of clozapine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or result of estradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
Local anesthetics are commonly safe. Nevertheless, a person may working experience moderate side effects. According to the method of supply, these side effects may consist of:
pentobarbital will decrease the extent or impact of tinidazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
You will find there's challenge with information and facts submitted for this request. Evaluation/update the data highlighted underneath and resubmit the form.
pentobarbital will reduce the level or outcome of midazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the level or result of lopinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
pentobarbital will lower the extent or result of tofacitinib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Lack of, or reduced reaction to tofacitinib may happen when coadministered with powerful CYP3A4 inducers
pentobarbital will more info minimize the extent or influence of repaglinide by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.